Well if it can’t be done, it can’t be done. Since you seem to have a firm handle on this one, what’s your thoughts on CGC’s Martha Stewart CBD line coming out. If your unaware it doesn’t sound like they will do anything until FDA gives whatever guidance, I do here the pet line maybe coming out next month however. There one of 7 bigger market companies that will be releasing with the FDA guidance, but this one bothers me more than the others. Deep pockets, promoting, ads. My concern is to establish a foot hold they start with kill the competition and start by selling at ½ price of the others, which would bring all the older players and new ones to play follow the leader. A frenzy if you will in the market place. What’s your thoughts on how CVSI will play it, or should play it.
Market Data 
Markets 
AI
